Value Bridge — ST. JOSEPHS UNIVERSITY MEDICAL CENT
Current $-117M → Target $-99M (+$17.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-116.8M
Current EBITDA
$-99.1M
Target EBITDA
+$17.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$4.0M
Payer Mix Optimization
$9.6M
Cost to Collect Reduction
$3.2M
Clean Claim Improvement
$2.4M
Volume & Rate Growth
$16.0M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-117M to $-99M. The highest-impact lever is Volume & Rate Growth at $6.4M probability-weighted.
IC talking point: "We see $18M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $195M in equity value creation."